Phosphorylation levels of BCR-ABL, CrkL, AKT and STAT5 in imatinib-resistant chronic myeloid leukemia cells implicate alternative pathway usage as a survival strategy

Iman Jilani, Hagop Kantarjian, Mercedes Gorre, Jorge Cortes, Oliver Ottmann, Kapil Bhalla, Francis J. Giles, Maher Albitar

Research output: Contribution to journalArticlepeer-review

20 Scopus citations

Fingerprint

Dive into the research topics of 'Phosphorylation levels of BCR-ABL, CrkL, AKT and STAT5 in imatinib-resistant chronic myeloid leukemia cells implicate alternative pathway usage as a survival strategy'. Together they form a unique fingerprint.

Medicine & Life Sciences